Hsp90 inhibitor ganetespib sensitizes non-small cell lung cancer to radiation but has variable effects with chemoradiation
In the pivotal SURPASS-2 trial (n=1,879), tirzepatide at all doses (5 mg, 10 mg, 15 mg) demonstrated both non-inferiority and superiority to semaglutide 1 mg injection for A1C reduction (-2.01% to -2.30% vs -1.86%) and body weight loss (-7.6 to -12.4 kg vs -5.7 kg)
Only a few of the popular peptides meet the first requirement and none meet the second
personal AND family history of MTC and MEN-2 , sleep apnea, T1/T2 diabetes, retinopathy, warfarin use, pancreatitis history, severe depression, fatty liver, CHF and PCOS
Platform Disclaimer: SkinnyRx (operated by Lean Rx, Inc.) operates as a telehealth platform and is not a healthcare provider